Literature DB >> 8385345

The APC gene product in normal and tumor cells.

K J Smith1, K A Johnson, T M Bryan, D E Hill, S Markowitz, J K Willson, C Paraskeva, G M Petersen, S R Hamilton, B Vogelstein.   

Abstract

The APC gene has been found to be mutated during the development of sporadic colorectal tumors as well as in the germ line of familial adenomatous polyposis patients. To facilitate the characterization of both normal and mutant APC protein, a series of monoclonal and polyclonal antibodies specific for the APC protein was produced. When lymphoblastoid cell lines derived from seven familial adenomatous polyposis patients with known mutations were analyzed by Western blot, an approximately 300-kDa protein corresponding to the predicted size of full-length APC was detected in all 7 cell lines. In addition, truncated APC proteins corresponding to the product of the known mutated alleles could be detected in 4 of the 7 lines. Similar analysis of 23 colon carcinoma and 9 adenoma cell lines revealed truncated proteins in 24 (75%) of the cell lines. Moreover, 26 (81%) of the colon tumor lines were totally devoid of the normal, full-length protein. In contrast, Western blot analysis of 40 cell lines derived from sporadic tumors of other organs detected only full-length APC. Immunohistochemical analysis of APC in normal colonic mucosa revealed cytoplasmic staining with more intense staining in the basolateral margins of the epithelial cell. This staining was markedly increased in the upper portions of the crypts, suggesting an increased level of expression with maturation. These studies provide some initial clues to the function of the cytoplasmic protein APC and demonstrate the feasibility of identifying APC mutations by direct analysis of the APC protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385345      PMCID: PMC46193          DOI: 10.1073/pnas.90.7.2846

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients.

Authors:  Y Miyoshi; H Ando; H Nagase; I Nishisho; A Horii; Y Miki; T Mori; J Utsunomiya; S Baba; G Petersen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Loss of heterozygosity involving the APC and MCC genetic loci occurs in the majority of human esophageal cancers.

Authors:  R F Boynton; P L Blount; J Yin; V L Brown; Y Huang; Y Tong; T McDaniel; C Newkirk; J H Resau; W H Raskind; R C Haggitt; B J Reid; S J Meltzer
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

3.  Classification of human colorectal adenocarcinoma cell lines.

Authors:  A Leibovitz; J C Stinson; W B McCombs; C E McCoy; K C Mazur; N D Mabry
Journal:  Cancer Res       Date:  1976-12       Impact factor: 12.701

4.  A gene regulating the heat shock response in Escherichia coli also affects proteolysis.

Authors:  T A Baker; A D Grossman; C A Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

5.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

6.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene.

Authors:  Y Miyoshi; H Nagase; H Ando; A Horii; S Ichii; S Nakatsuru; T Aoki; Y Miki; T Mori; Y Nakamura
Journal:  Hum Mol Genet       Date:  1992-07       Impact factor: 6.150

7.  Cell culture of human colon adenomas and carcinomas.

Authors:  J K Willson; G N Bittner; T D Oberley; L F Meisner; J L Weese
Journal:  Cancer Res       Date:  1987-05-15       Impact factor: 12.701

8.  Specific cytogenetic abnormalities and k-ras mutation in two new human colorectal-adenoma-derived cell lines.

Authors:  A C Williams; S J Harper; C J Marshall; R W Gill; R A Mountford; C Paraskeva
Journal:  Int J Cancer       Date:  1992-11-11       Impact factor: 7.396

9.  The isolation and characterization of colorectal epithelial cell lines at different stages in malignant transformation from familial polyposis coli patients.

Authors:  C Paraskeva; B G Buckle; D Sheer; C B Wigley
Journal:  Int J Cancer       Date:  1984-07-15       Impact factor: 7.396

10.  Establishment and characterization of human colorectal cancer cell lines.

Authors:  J A McBain; J L Weese; L F Meisner; W H Wolberg; J K Willson
Journal:  Cancer Res       Date:  1984-12       Impact factor: 12.701

View more
  114 in total

Review 1.  The ins and outs of APC and beta-catenin nuclear transport.

Authors:  Beric R Henderson; Francois Fagotto
Journal:  EMBO Rep       Date:  2002-09       Impact factor: 8.807

2.  A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcription.

Authors:  Kenneth Ewan; Bozena Pajak; Mark Stubbs; Helen Todd; Olivier Barbeau; Camilo Quevedo; Hannah Botfield; Rodrigo Young; Ruth Ruddle; Lee Samuel; Alysia Battersby; Florence Raynaud; Nicholas Allen; Stephen Wilson; Branko Latinkic; Paul Workman; Edward McDonald; Julian Blagg; Wynne Aherne; Trevor Dale
Journal:  Cancer Res       Date:  2010-07-07       Impact factor: 12.701

Review 3.  The intestinal stem cell.

Authors:  Luis A Chia; Calvin J Kuo
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

4.  Colon Tumors with the Simultaneous Induction of Driver Mutations in APC, KRAS, and PIK3CA Still Progress through the Adenoma-to-carcinoma Sequence.

Authors:  Jamie N Hadac; Alyssa A Leystra; Terrah J Paul Olson; Molly E Maher; Susan N Payne; Alexander E Yueh; Alexander R Schwartz; Dawn M Albrecht; Linda Clipson; Cheri A Pasch; Kristina A Matkowskyj; Richard B Halberg; Dustin A Deming
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

5.  Expressions of two adenomatous polyposis coli and E-cadherin proteins on human colorectal cancers.

Authors:  Koh Furuta; Shingo Yoshioka; Satoko Okabe; Masato Ikeda; Mihoko Oginosawa; Seiyo Ikeda; Yoshifuku Nakayama; Masahiro Kikuchi; Stanley R Hamilton
Journal:  Virchows Arch       Date:  2003-02-11       Impact factor: 4.064

6.  A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ mice.

Authors:  A R Shoemaker; A R Moser; C A Midgley; L Clipson; M A Newton; W F Dove
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 7.  Apoptotic pathways as a therapeutic target for colorectal cancer treatment.

Authors:  Aman M Abraha; Ezra B Ketema
Journal:  World J Gastrointest Oncol       Date:  2016-08-15

8.  Alpha-catenin is essential in intestinal adenoma formation.

Authors:  Hiroyuki Shibata; Hiroshi Takano; Masaki Ito; Hisashi Shioya; Morihisa Hirota; Hiroshi Matsumoto; Yuichi Kakudo; Chikashi Ishioka; Tetsu Akiyama; Yumi Kanegae; Izumu Saito; Tetsuo Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

9.  Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein.

Authors:  S Munemitsu; I Albert; B Souza; B Rubinfeld; P Polakis
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Authors:  Yutaka Suehiro; Chi Wai Wong; Lucian R Chirieac; Yutaka Kondo; Lanlan Shen; C Renee Webb; Yee Wai Chan; Annie S Y Chan; Tsun Leung Chan; Tsung-Teh Wu; Asif Rashid; Yuichiro Hamanaka; Yuji Hinoda; Rhonda L Shannon; Xuemei Wang; Jeffrey Morris; Jean-Pierre J Issa; Siu Tsan Yuen; Suet Yi Leung; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.